ATTENTION DEFICIT HYPERACTIVITY DISORDER EXECUTIVE SUMMARY THE FACTS PATIENT STATISTICS PATIENT MODEL DRUG GROWTH DRIVERS DRUG GROWTH RISKS/DAMPENERS GLOBAL ADHD MARKET GLOBAL SALES SPLIT CURRENT TREATMENTS ANALYSIS OF LEADING BRANDS STIMULANTS NON STIMULANT GLOBAL SALES FORECASTS OF CURRENT TREATMENTS 2005 – 2012 NEW DRUGS IN R&D ANALYSIS OF PHASE III DRUGS GLOBAL SALES FORECASTS OF PHASE III ADHD DRUGS 2006 – 2012 ANALYSIS OF PHASE II DRUGS GLOBAL SALES FORECASTS OF PHASE II ADHD DRUGS 2006 – 2012 . COMPETITOR RATIO ANALYSIS COMPETITOR RATIO ANALYSIS - COMPANIES DISCONTINUATION OF DRUGS ADHD APPENDIX 1 ADHD APPENDIX 2 ADHD APPENDIX 3 ADHD APPENDIX 4 ADHD APPENDIX 5 ADHD GLOSSARY ADHD REFERENCES ACRONYMS
